DK0971714T3 - Metode til anvendelse af cyklooxygenase-2-inhibitorer til behandling og forebyggelse af demens - Google Patents

Metode til anvendelse af cyklooxygenase-2-inhibitorer til behandling og forebyggelse af demens

Info

Publication number
DK0971714T3
DK0971714T3 DK98912108T DK98912108T DK0971714T3 DK 0971714 T3 DK0971714 T3 DK 0971714T3 DK 98912108 T DK98912108 T DK 98912108T DK 98912108 T DK98912108 T DK 98912108T DK 0971714 T3 DK0971714 T3 DK 0971714T3
Authority
DK
Denmark
Prior art keywords
cyclooxygenase
inhibitors
dementia
prevention
treatment
Prior art date
Application number
DK98912108T
Other languages
Danish (da)
English (en)
Inventor
Philip Needleman
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Application granted granted Critical
Publication of DK0971714T3 publication Critical patent/DK0971714T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DK98912108T 1997-04-03 1998-03-30 Metode til anvendelse af cyklooxygenase-2-inhibitorer til behandling og forebyggelse af demens DK0971714T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4391697P 1997-04-03 1997-04-03
PCT/US1998/006143 WO1998043648A1 (en) 1997-04-03 1998-03-30 Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of dementia

Publications (1)

Publication Number Publication Date
DK0971714T3 true DK0971714T3 (da) 2002-11-04

Family

ID=21929578

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98912108T DK0971714T3 (da) 1997-04-03 1998-03-30 Metode til anvendelse af cyklooxygenase-2-inhibitorer til behandling og forebyggelse af demens

Country Status (13)

Country Link
EP (1) EP0971714B1 (de)
JP (1) JP2002514208A (de)
AT (1) ATE225660T1 (de)
AU (1) AU725697B2 (de)
BR (1) BR9807920A (de)
CA (1) CA2285434A1 (de)
DE (1) DE69808607T2 (de)
DK (1) DK0971714T3 (de)
ES (1) ES2185154T3 (de)
HK (1) HK1024872A1 (de)
PT (1) PT971714E (de)
WO (1) WO1998043648A1 (de)
ZA (1) ZA982808B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6727238B2 (en) 1998-06-11 2004-04-27 Pfizer Inc. Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
US6294558B1 (en) 1999-05-31 2001-09-25 Pfizer Inc. Sulfonylbenzene compounds as anti-inflammatory/analgesic agents

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9420616D0 (en) * 1994-10-12 1994-11-30 Merck Sharp & Dohme Method, compositions and use
CA2276945C (en) * 1993-11-30 2006-08-01 G.D. Searle & Co. Tricyclic-substituted pyrazolyl benzenesulfonamides and pharmaceutical compositions thereof
US5486534A (en) * 1994-07-21 1996-01-23 G. D. Searle & Co. 3,4-substituted pyrazoles for the treatment of inflammation
US5547975A (en) * 1994-09-20 1996-08-20 Talley; John J. Benzopyranopyrazolyl derivatives for the treatment of inflammation
US5696143A (en) * 1994-09-20 1997-12-09 Talley; John J. Benz G! indazolyl derivatives for the treatment of inflammation
EP0828718A1 (de) * 1995-06-02 1998-03-18 G.D. SEARLE & CO. Heterocyclo-substituierte hydroxaminsäurederivate als cyclooxygenase-2 und 5-lipoxygenase inhibitoren
US5643933A (en) * 1995-06-02 1997-07-01 G. D. Searle & Co. Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors
US5700816A (en) * 1995-06-12 1997-12-23 Isakson; Peter C. Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor
CA2224563A1 (en) * 1995-06-12 1996-12-27 G.D. Searle & Co. Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations
DE69635048T2 (de) * 1995-06-12 2006-02-16 G.D. Searle & Co. Mittel, enthaltend einen cyclooxygenase-2 inhibitor und einen 5-lipoxygenase inhibitor
DE69739003D1 (de) * 1996-04-12 2008-10-30 Searle Llc Substituierte Benzensulfonamid-Derivate als Wirkstoff-Vorläufer von COX-2 Inhibitoren

Also Published As

Publication number Publication date
DE69808607T2 (de) 2003-06-26
CA2285434A1 (en) 1998-10-08
EP0971714B1 (de) 2002-10-09
JP2002514208A (ja) 2002-05-14
ATE225660T1 (de) 2002-10-15
PT971714E (pt) 2002-12-31
AU725697B2 (en) 2000-10-19
WO1998043648A1 (en) 1998-10-08
AU6590498A (en) 1998-10-22
ZA982808B (en) 1999-04-06
ES2185154T3 (es) 2003-04-16
EP0971714A1 (de) 2000-01-19
BR9807920A (pt) 2000-02-22
DE69808607D1 (de) 2002-11-14
HK1024872A1 (en) 2000-10-27

Similar Documents

Publication Publication Date Title
ATE217865T1 (de) Verbindungen zur hemmung von phosphodiesrerase iv
AP9901478A0 (en) Compounds for the treatment of ischemia.
DK0932402T3 (da) Metode til anvendelse af cyclooxygenase-2-inhibitorer ved behandling og forebyggelse af neoplasi
GT200000103A (es) Trifluorbutenos nematocidas.
MX9804623A (es) Precursores inactivos de farmacos inhibidores de trombina.
TR200200205T2 (tr) MEK inhibitörleri kullanılarak kronik ağrının tedavi edilmesi
NO942064L (no) yminhibitorer
MX9304638A (es) Composicion para tratar e inhibir las ulceras gastricas y duodenales.
DK0981341T3 (da) Anvendelse af betulinsyrederivater til behandling og forebyggelse af melanom
TR199901191T2 (xx) Benzamidoaldehitlerin sistein proteaz� inhibit�r� olarak kullan�m�.
ATE148130T1 (de) Typ-iv-dipeptidyl-aminopeptidase-inhibitoren
ATE225351T1 (de) Thienopyridin und thienopyrimidinderivate und ihre verwendung als entzündungshemmende mittel
AP2001002205A0 (en) Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase.
NO996578L (no) Urokinase-inhibitorer
SE9602263D0 (sv) New amino acid derivatives
DK1169337T3 (da) Steroidnitrater til behandlingen af oxidativ beskadigelse og endothel dysfunktion
WO1998036730A3 (de) Zubereitungen für die behandlung von rosacea
WO2004032908A3 (en) Method of inhibiting angiogenesis
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
DK0996435T3 (da) Aminosyrederivater anvendelige til behandling af slagtilfælde
DK0971714T3 (da) Metode til anvendelse af cyklooxygenase-2-inhibitorer til behandling og forebyggelse af demens
DK0674521T3 (da) Fremgangsmåde til behandling af kronisk prostatitis med 17beta-N-tertbutylcarbamoyl-4-aza-5a-andost-1-en-3-on
NO943765L (no) Aryloksybenzen-herbicidmidler
PT1276722E (pt) Inibidores de naftamidina-uroquinase
AP2002002493A0 (en) Sodium-hydrogen exchanger type 1 inhibitor crystals.